Managing pain after chest surgery is a major challenge for patients and doctors alike. One common approach has been using gabapentin, a medication often used to manage nerve pain, before the procedure to help keep patients comfortable during recovery.
However, a review of data from 748 adults undergoing thoracic surgery shows that gabapentin did not provide a meaningful benefit. Specifically, patients who received the drug did not report less rest pain at the 24-hour mark compared to those who received a placebo. The study also found no significant change in how much opioid medication patients used or in the development of long-term pain.
While the results are not definitive because the evidence is of low certainty, the data suggests gabapentin may not be the best tool for this specific surgery. Interestingly, there was a slight trend toward worse pain when patients coughed, though this was not statistically significant. Safety checks showed no significant difference in side effects like nausea or sedation between the two groups.
